From: Global gene expression profile progression in Gaucher disease mouse models
Categories | Lung | Liver | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | 9 V/null | 4L | 9 V/null | 4L | ||||||||
 | No. | % | p-value | No. | % | p-value | No. | % | p-value | No. | % | p-value |
catalytic activity | 440 | 38% | 1.49E-06 | 527 | 39% | 4.24E-09 | 160 | 40% | 3.37E-04 | 157 | 39% | 2.61E-03 |
intracellular signaling cascade | 136 | 12% | 7.49E-10 | 166 | 12% | 2.40E-10 | 50 | 13% | 7.50E-04 | 46 | 11% | 1.24E-03 |
kinase activity | 87 | 8% | 8.41E-04 | 98 | 7% | 1.41E-03 | 34 | 9% | 8.07E-03 | 31 | 7% | 4.46E-02 |
lipid metabolic process | 66 | 6% | 7.62E-04 | 73 | 5% | 1.43E-02 | 37 | 9% | 1.22E-05 | 30 | 7% | 7.71E-04 |
macrophage activation | 119 | 10% | 4.50E-04 | 83 | 6% | 3.29E-03 | 24 | 6% | 5.74E-03 | 26 | 6% | 6.93E-03 |
transcription | 195 | 17% | 1.44E-03 | 276 | 20% | 2.33E-08 | 83 | 21% | 2.50E-03 | 76 | 19% | 4.17E-03 |
cell death | 75 | 7% | 1.36E-04 | 89 | 7% | 3.83E-04 | 27 | 7% | 4.93E-02 | Â | Â | Â |
cytoskeleton | 78 | 7% | 3.92E-02 | 87 | 7% | 5.96E-03 | Â | Â | Â | Â | Â | Â |
lysosome | 29 | 3% | 1.91E-05 | 27 | 2% | 1.43E-03 | Â | Â | Â | Â | Â | Â |
response to stress | 79 | 7% | 1.52E-03 | 91 | 7% | 1.20E-02 | Â | Â | Â | Â | Â | Â |
transport | 219 | 19% | 2.14E-04 | 255 | 19% | 8.03E-03 | Â | Â | Â | Â | Â | Â |
immune response | 54 | 5% | 4.68E-03 | Â | Â | Â | Â | Â | Â | Â | Â | Â |